CohBar, Inc. ( NASDAQ:CWBR – Get Free Report ) was up 4.7% during mid-day trading on Monday .
The stock traded as high as $0.51 and last traded at $0.51.
Approximately 155 shares traded hands during mid-day trading, a decline of 93% from the average daily volume of 2,369 shares. The stock had previously closed at $0.49.
CohBar Stock Up 4.7 % The firm’s 50 day simple moving average is $0.49 and its 200-day simple moving average is $0.
53. CohBar Company Profile ( Get Free Report ) CohBar, Inc, a clinical stage biotechnology company, develops mitochondria and peptides based therapeutics for the treatment of chronic and age-related diseases. It develops CB4211, a therapeutic that is in Phase 1a/1b clinical trial for the treatment of nonalcoholic steatohepatitis and obesity; and CB5138 Analogs, which is in preclinical study to treat idiopathic pulmonary fibrosis and other fibrotic diseases.
Read More Five stocks we like better than CohBar Pros And Cons Of Monthly Dividend Stocks Is Monolithic Power Systems a Screaming Buy After Near 40% Drop? How to Calculate Inflation Rate Applied Materials Market Capitulates: Now is the Time to Buy The Risks of Owning Bonds 3 Ultra-High Dividend Yield Stocks for the New Year Receive News & Ratings for CohBar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CohBar and related companies with MarketBeat.com's FREE daily email newsletter ..
Business
CohBar (NASDAQ:CWBR) Trading Up 4.7% – Time to Buy?
CohBar, Inc. (NASDAQ:CWBR – Get Free Report) was up 4.7% during mid-day trading on Monday . The stock traded as high as $0.51 and last traded at $0.51. Approximately 155 shares traded hands during mid-day trading, a decline of 93% from the average daily volume of 2,369 shares. The stock had previously closed at $0.49. [...]